American Society of Clinical Oncology - Clinical Cancer Advances 2017

Advance of the Year: Immunotherapy 2.0

Advances in Cancer Treatment Beyond Immunotherapy

Advances in Pacient Care

Advances in Tumor Biology

Cancer Risk, Prevention, and Screening

Looking to the Future

Advances in Pacient Care - -

Artigo	Autor(es)	Referência
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial.	Basch Ethan, Deal Allison M, Kris Mark G, Scher Howard I, Hudis Clifford A, Sabbatini Paul, Rogak Lauren, Bennett Antonia V, Dueck Amylou C, Atkinson Thomas M, Chou Joanne F, Dulko Dorothy, Sit Laura, Barz Allison, Novotny Paul, Fruscione Michael, Sloan Jeff A, Schrag Deborah	Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Feb; 34(Feb):557-65. doi: 10.1200/JCO.2015.63.0830. pii: .

Nenhuma revista foi definida para este congresso.

Combined Modality Therapy	-
Longer Hormone Therapy Further Reduces Breast Cancer Recurrence	-
New Concerns About Laparoscopic Rectal Cancer Surgery	-
Targeted Therapy	-

Addressing Health Literacy in The Era of Precision Medicine	-
Better Way to Prevent Chemotherapy-Triggered Nause	-
Patient Navigation Program Improves Compliance With Cancer Therapy	-
Patient Self-Reporting of Symptoms Improves Care	-

Additional Genes Linked to Ovarian Cancer Risk	-
Broader Testing Uncovers Unexpected Cancer Predisposition Gene Mutations	-
Daily Vitamin B Reduces Skin Cancer Risk	-
Many Children With Cancer May Carry Hereditary Gene Mutations	-
New Understanding of Barriers to Cancer Screening Among Latinas	-
Pancreatic Cancer Susceptibility Genes Identified, and New Opportunities for Screening and Prevention	-

Checkpoint Inhibitors work well Against Hypermutated Cancers	-
Emerging Clues on Patient Selection	-
Progress With Immune Checkpoint Inhibitors 10	-

Expanding Targeted Therapy Options for Ovarian Cancer	-
Liquid Biopsies Help Personalize Cancer Therapy	-